Business
Cheelcare Receives Canadian Patent for Companion Power Assist Platform
Canadian Patent Strengthens Intellectual Property Protection for the Companion PlatformMarkham, Ontario--(Newsfile Corp. - May 28, 2026) - Cheelcare Inc. (TSXV: CHER) (OTC: CHCRF) ("Cheelcare" or the "Company"), a Canadian innovator in advanced mobility solutions, today announced that the Canadian Intellectual Property Office ("CIPO") has officially granted Canadian Patent No. 3090535 covering core technologies underlying the Company's Companion platform, further strengthening Cheelcare's...
About this update from Cheelcare Inc.
[{"type":"text","content":"Canadian Patent Strengthens Intellectual Property Protection for the Companion Platform","length":87,"tagName":"p","attribs":{"class":"nfSubHeading"},"className":""},{"type":"text","content":"Markham, Ontario--(Newsfile Corp. - May 28, 2026) - Cheelcare Inc. (TSXV: CHER) (OTC: CHCRF) ("Cheelcare" or the "Company"), a Canadian innovator in advanced mobility solutions, today announced that the Canadian Intellectual Property Office ("CIPO") has officially granted Canadian Patent No. 3090535 covering core technologies underlying the Company's Companion platform, further strengthening Cheelcare's intellectual property portfolio.","length":477,"tagName":"p"},{"type":"text","content":"The patent, titled Chair-Drive Interface Assembly, Wheelchair and/or Drive, was originally filed on August 19, 2020 and issued on May 26, 2026. The patent term extends 20 years from the original filing date. A corresponding U.S. patent related to Companion technologies was previously granted following a filing made on August 18, 2020.","length":336,"tagName":"p"},{"type":"text","content":"The patent protects core interface technologies that enable the Companion power assist system to securely integrate with a manual wheelchair while remaining portable and easy for users to operate independently. The Company believes the Canadian patent, together with previously granted U.S. patent protection and additional pending filings associated with the Companion and Curio platforms, further strengthens Cheelcare's intellectual property portfolio and supports the long-term commercialization of its mobility solutions. Management believes the Company's expanding intellectual property portfolio supports long-term product differentiation as reimbursement-supported access and commercial adoption continue to grow.","length":729,"tagName":"p"},{"type":"text","content":""The Companion platform represents years of focused engineering and product development aimed at improving mobility and independence for manual wheelchair users," said Eugene Cherny, Chief Executive Officer of Cheelcare. "Securing patent protection in both Canada and the United States is an important milestone as we continue expanding reimbursement-supported access, growing dealer relationships, and expanding commercialization across North America.&...